Korelasi nilai rasio neutofil-limfosit dengan kadar ureum dan kreatinin pada pasien hemodialisa rutin di RSU Wiradadi Husada
DOI: https://doi.org/10.56922/chi.v3i3.4088
Creatinine Hemodialysis NLR Urea
Abstract
Background: Chronic kidney disease is characterized by a progressive and irreversible decline in kidney function, which may require hemodialysis therapy at an advanced stage. Patients undergoing routine hemodialysis are at risk of chronic inflammation, which can be reflected by the Neutrophil-to-Lymphocyte Ratio (NLR), while urea and creatinine levels can indicate the accumulation of metabolic waste products in the body.
Purpose: To determine the correlation between NLR and urea and creatinine levels in patients undergoing routine hemodialysis at RSU Wiradadi Husada.
Method: This study used an analytical observational design with a cross-sectional approach and consecutive sampling technique. A total of 42 patients undergoing routine hemodialysis were examined in June 2026. NLR values were obtained from complete blood count results, while urea and creatinine levels were obtained from serum examinations. Data were analyzed using the Spearman correlation test.
Results: The results showed no significant correlation between NLR and urea levels (r = 0.054; p = 0.736) or between NLR and creatinine levels (r = −0.189; p = 0.230).
Conclusion: There was no significant correlation between NLR and urea or creatinine levels in patients undergoing routine hemodialysis at RSU Wiradadi Husada.
Downloads
References
Abdelrasoul, A., Westphalen, H., Saadati, S., & Shoker, A. (2021). Hemodialysis biocompatibility mathematical models to predict the inflammatory biomarkers released in dialysis patients based on hemodialysis membrane characteristics and clinical practices. Scientific reports, 11(1), 23080.
Anees, M., Jawed, K., Ali, Z., Khan, A. M., & Siddiqui, N. A. (2025). Association of neutrophil-to-lymphocyte ratio and hemodialysis access failure in patients with end stage renal disease: A systematic review and meta-analysis. Journal of Vascular Access, 26(4), 1139–1150. https://doi.org/10.1177/11297298241276560
Bowry, S. K., Kircelli, F., Himmele, R., & Nigwekar, S. U. (2021). Blood-incompatibility in haemodialysis: Alleviating inflammation and effects of coagulation. Clinical Kidney Journal, 14(Suppl 4), i59–i71. https://doi.org/10.1093/ckj/sfab185
Cohen, G. (2020). Immune dysfunction in uremia 2020. Toxins, 12(7), 439. https://doi.org/10.3390/toxins12070439
Ebert, T., Neytchev, O., Witasp, A., Kublickiene, K., Stenvinkel, P., & Shiels, P. G. (2021). Inflammation and oxidative stress in chronic kidney disease and dialysis patients. Antioxidants & Redox Signaling, 35(17), 1426–1448.
Kementerian Kesehatan Republik Indonesia. (2019). Laporan nasional Riskesdas 2018. Badan Penelitian dan Pengembangan Kesehatan. https://www.badankebijakan.kemkes.go.id/repositori/id/eprint/3514/
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. (2024). KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International, 105(4S), S117–S314. https://doi.org/10.1016/j.kint.2023.10.018
Levin, A., Stevens, P. E., Bilous, R. W., Coresh, J., de Francisco, A. L. M., & Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. (2013). KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International Supplements, 3(1), 1–150.
Nie, H., Liu, Y., Zeng, X., & Chen, M. (2024). Neutrophil-to-lymphocyte ratio is associated with sarcopenia risk in overweight maintenance hemodialysis patients. Scientific Reports, 14(1), 3669. https://doi.org/10.1038/s41598-024-54056-2
Parmelia, M., & Sutarka, I. N. (2023). Neutrophil-lymphocyte ratio as predictor of mortality in regular hemodialysis patients at Tabanan General Hospital. Unram Medical Journal, 12(2). https://doi.org/10.29303/jk.v12i2.4389
Rashid, I., Tiwari, P., D’Cruz, S., & Jaswal, S. (2023). Prognostic importance of neutrophil-lymphocyte ratio in non-dialysis chronic kidney disease patients—a hospital-based prospective cohort. Exploration of Medicine, 4(3), 299–313. https://doi.org/10.37349/emed.2023.00141
Romagnani, P., Agarwal, R., Chan, J. C. N., Levin, A., Kalyesubula, R., Karam, S., Nangaku, M., Rodríguez-Iturbe, B., & Anders, H. J. (2025). Chronic kidney disease. Nature Reviews Disease Primers, 11(1), 8. https://doi.org/10.1038/s41572-024-00589-9
Rosner, M. H., Reis, T., Husain-Syed, F., Vanholder, R., Hutchison, C., Stenvinkel, P., Blankestijn, P. J., Cozzolino, M., Juillard, L., Kashani, K., Kaushik, M., Kawanishi, H., Massy, Z., Sirich, T. L., Zuo, L., & Ronco, C. (2021). Classification of uremic toxins and their role in kidney failure. Clinical Journal of the American Society of Nephrology, 16(12), 1918–1928. https://doi.org/10.2215/CJN.02660221
Sambo, N. A., Sasmithae, L., & Nugrahini, S. (2023). Correlation between neutrophil-lymphocyte ratio and urea serum in hemodialysis patients at Dr. Doris Sylvanus Hospital. Indonesian Journal of Clinical Pathology and Medical Laboratory, 30(1), 83–86. https://doi.org/10.24293/ijcpml.v30i1.2076
Wang, J., Xu, M.-C., Huang, L.-J., Li, B., Yang, L., & Deng, X. (2023). Value of neutrophil-to-lymphocyte ratio for diagnosing sarcopenia in patients undergoing maintenance hemodialysis and efficacy of Baduanjin exercise combined with nutritional support. Frontiers in Neurology, 14, 1072986. https://doi.org/10.3389/fneur.2023.1072986
Yang, K., Yang, K., Pan, S., He, Q., & Jin, J. (2023). Progress in the application of the neutrophil-to-lymphocyte ratio in dialysis-related complications. Renal Failure, 45(2), 2259996.
Yu, X., & Wang, X. (2021). Neutrophil-to-lymphocyte ratio in relation to the risk of all-cause mortality and cardiovascular events in patients with chronic kidney disease: A systematic review and meta-analysis. Renal Failure, 43(1), 54–61. https://doi.org/10.1080/0886022X.2020.1832521.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 JOURNAL OF Community Health Issues
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
